NANOSCRIBE GMBH & CO KG

Their core work

Nanoscribe is a German photonics technology company specializing in precision micro- and nanofabrication, contributing advanced optical and photonic component capabilities to research consortia. In H2020 projects they appear as a specialist technology contributor — providing fabrication expertise for both miniaturized medical imaging devices (handheld OCT) and next-generation photonic computing architectures. Their project portfolio spans two distinct but technically related application domains: medical point-of-care diagnostics and ultra-low-energy photonic in-memory computing. Both domains rely on the same underlying capability: manufacturing optically precise structures at the micro- and nanoscale.

What they specialise in

How they've shifted over time

Nanoscribe's two H2020 projects start just one year apart (2020 and 2021), so the evolution is compressed but meaningful. Their first project (HandheldOCT) anchors them in applied medical photonics — miniaturized imaging for clinical diagnostics. Their second project (PHOENICS) pivots sharply toward frontier computing photonics: coherent frequency combs, phase-change materials, and in-memory computing at femtojoule energy levels. The shift signals a deliberate move from health-application optics toward deep-tech photonic computing infrastructure — a higher-TRL-ceiling domain with longer commercialization timelines but larger market potential.

Nanoscribe is moving toward photonic computing infrastructure — if this direction continues, future collaborations are likely in FET/EIC-tier projects on neuromorphic or optical computing rather than medical devices.

How they like to work

Nanoscribe participates exclusively as a consortium partner — they have never led an H2020 project — suggesting they contribute specific technology or fabrication capability rather than driving project direction. With 16 unique partners across 6 countries from just 2 projects, they appear to join large, international RIA consortia. This profile is consistent with a specialist supplier embedded in research teams to provide hardware, components, or fabrication services that others cannot replicate internally.

Nanoscribe has connected with 16 distinct consortium partners across 6 countries through only 2 projects — an unusually high partner-to-project ratio indicating involvement in large, multi-partner consortia. Their geographic footprint is European, spanning multiple EU member states within the ICT and FET research communities.

What sets them apart

Nanoscribe occupies a rare niche as an industrial company contributing precision photonic fabrication capabilities to frontier research consortia — a role most academic or purely R&D organizations cannot fill. Their combination of medical optics experience (OCT diagnostics) and advanced photonic computing expertise (frequency combs, phase-change materials) makes them a credible bridge between applied health tech and next-generation computing hardware. For consortium builders, they bring industrial-grade manufacturing know-how into research environments that typically lack it.

Highlights from their portfolio

• PHOENICS
  The largest of their two projects by funding (EUR 344,531), targeting petascale in-memory computing via nanophotonics — one of the most ambitious computing paradigms in current EU research, positioned in the Research Excellence pillar (FET).
• HandheldOCT
  Demonstrates Nanoscribe's applied side — miniaturizing optical coherence tomography for point-of-care use, bridging their nanofabrication expertise directly into clinical diagnostic devices.